ABOUT CONFERENCE:

The 3rd International Conference on Diabetes and Endocrinology 2026, is a premier global platform dedicated to advancing excellence in diabetes care, endocrine research, clinical practice, education, and healthcare innovation. This international event brings together endocrinologists, diabetologists, physicians, clinicians, researchers, academicians, nutritionists, nurses, public health experts, healthcare administrators, and industry professionals to share knowledge, present pioneering research, and foster meaningful collaboration across the diabetes and endocrinology community.

Building on the success of its previous editions, the conference addresses current challenges and emerging opportunities in the prevention, diagnosis, and management of diabetes and endocrine disorders. The scientific program emphasizes evidence-based medicine, personalized and precision care, metabolic and hormonal health, digital health technologies, translational research, and interdisciplinary collaboration. Participants will benefit from a comprehensive agenda featuring keynote lectures, oral and poster presentations, panel discussions, workshops, and interactive networking sessions, designed to deliver an engaging and impactful learning experience.

The conference aims to bridge the gap between research and clinical practice by promoting dialogue, professional development, and innovation in metabolic and endocrine healthcare. By fostering an inclusive and collaborative environment, the 3rd International Conference on Diabetes and Endocrinology 2026, taking place on October 05–06, 2026, in Madrid, Spain, empowers healthcare professionals to exchange ideas, build lasting partnerships, and contribute to improving patient outcomes and advancing global endocrine health.

WHY ATTEND?

Gain insights into the latest advancements in diabetes research, endocrinology, and metabolic healthcare
Learn from internationally renowned keynote speakers and leading endocrinologists
Participate in scientific sessions, workshops, panel discussions, and poster presentations
Explore evidence-based approaches in diabetes management, hormonal disorders, and patient-centered care
Present your research on a prestigious international platform
Network with endocrinologists, diabetologists, clinicians, researchers, and industry leaders worldwide
Build global collaborations and multidisciplinary professional connections
Enhance career growth, clinical expertise, and academic development
Stay updated on emerging trends, technologies, and innovations in diabetes and endocrinology

WHO SHOULD ATTEND?

Endocrinologists and Diabetologists
Physicians and Clinical Specialists
Diabetes Educators and Nutritionists
Researchers and Scientists in Endocrinology and Metabolism
Nurses and Allied Healthcare Professionals
Public Health Professionals
Healthcare Administrators and Hospital Managers
Policy Makers and Healthcare Leaders
Undergraduate, Postgraduate, and PhD Scholars
Industry Professionals, Medical Device Manufacturers, and Pharmaceutical Experts

KEY HIGHLIGHTS:

High-impact keynote addresses by globally recognized experts in diabetes and endocrinology
Comprehensive scientific program covering diabetes, endocrine disorders, metabolism, and hormonal health
Oral and poster presentations showcasing cutting-edge research, clinical trials, and case studies
Interactive panel discussions and hands-on workshops led by academic and industry leaders
Strong focus on evidence-based medicine and personalized patient care
Sessions on diabetes prevention, treatment innovations, and endocrine system disorders
Insights into digital health, AI, telemedicine, and advanced diagnostic technologies
Global networking opportunities with professionals from academia, clinical practice, and industry
Young Researchers and Student Sessions with mentorship and career guidance
Opportunities for collaboration, knowledge exchange, and professional development
Broad international participation from diverse healthcare and scientific disciplines
Certification of participation and presentation

VISA ASSISTANCE:

Invitation Letter: Official invitation letters will be provided to confirmed and registered participants of the Diabetes and Endocrinology Conference.
Eligibility: Visa support is available for all registered speakers, delegates, students, exhibitors, and sponsors.
Visa Responsibility: Visa approval is solely at the discretion of the respective embassy or consulate, and the conference organizers cannot influence the outcome.
Application Timeline: Participants are strongly advised to apply for their visa well in advance to allow sufficient processing time.
Organizer Support: The organizing committee will assist with required documentation upon request after successful registration.
Contact for Assistance: Registered participants may contact the Conference Secretariat for visa-related guidance and support.
Registration Requirement: Visa assistance is provided only after successful completion of conference registration and payment.
Document Accuracy: Participants are responsible for ensuring that all submitted personal and travel details match their passport information.
Travel Planning: Delegates should make travel and accommodation arrangements only after visa approval.
Compliance: Participants must comply with all immigration rules and regulations of Spain throughout their stay.

PARTICIPATION BENEFITS:

Academic Speaker: Present advanced research in diabetes and endocrinology, clinical studies, or innovative therapeutic approaches. Engage with international experts, foster academic collaborations, and gain global recognition.
Student Speaker: Present student research projects, clinical studies, or preliminary findings. Gain international exposure, presentation experience, and expert feedback from leading specialists.
Delegate: Attend high-impact sessions to stay informed about the latest developments in diabetes care, endocrine research, and metabolic health. Network with global healthcare professionals and thought leaders.
Exhibitor: Showcase medical devices, diagnostic tools, pharmaceuticals, digital health solutions, or educational resources to a focused international audience. Strengthen brand visibility and connect with decision-makers.
Participant: Engage in scientific discussions, knowledge exchange, and professional networking focused on diabetes and endocrine healthcare advancements.
Poster Presenter: Present research findings, clinical case reports, or innovative healthcare solutions through interactive poster sessions. Receive constructive feedback and increase research visibility.
Sponsor: Promote your organization while demonstrating leadership in diabetes care, endocrinology, and healthcare innovation. Gain premium branding, sponsored session opportunities, and targeted engagement.
Young Researcher / Early-Career Professional: Highlight emerging research, develop professional skills, and connect with experienced mentors to accelerate academic and clinical career growth.
Industry Professional: Explore the latest diabetes and endocrinology solutions, medical technologies, pharmaceuticals, and policy developments. Build strategic partnerships with clinicians, researchers, and healthcare institutions.

SESSION AND TRACKS:

Track 1: Diabetes Research and Evidence-Based Practice

This track focuses on advancing diabetes care through robust scientific research and evidence-based clinical practice. It highlights randomized controlled trials, real-world evidence, and translational research that bridge laboratory discoveries with patient care. Emphasis is placed on clinical guidelines, research ethics, and quality improvement strategies. The goal is to enhance clinical decision-making and improve patient outcomes globally.

Track 2: Pathophysiology of Diabetes and Metabolic Disorders

This session explores the molecular, cellular, and physiological mechanisms driving diabetes and metabolic diseases. It examines insulin resistance, beta-cell failure, inflammation, and metabolic signaling pathways. Discussions focus on disease progression and potential therapeutic targets. The track supports a deeper understanding of metabolic dysfunction.

Track 3: Type 1 Diabetes – Mechanisms and Clinical Management

This track addresses autoimmune diabetes, early diagnosis, and long-term management strategies. It highlights advances in insulin delivery, immune-based therapies, and glucose monitoring technologies. Special focus is given to pediatric and adolescent diabetes care. The session emphasizes improving quality of life and long-term outcomes.

Track 4: Type 2 Diabetes – Prevention and Therapeutic Approaches

This session focuses on the prevention and management of Type 2 diabetes through lifestyle modification and pharmacological treatment. It addresses obesity, insulin resistance, and cardiometabolic risk factors. Discussions include patient-centered care models and long-term disease management. The track highlights strategies to reduce global disease burden.

Track 5: Prediabetes and Early Intervention Strategies

This track emphasizes early detection and preventive strategies to delay or prevent diabetes onset. It explores screening tools, behavioral interventions, and community-based prevention programs. Focus is placed on risk stratification and lifestyle modification. The session supports proactive public health approaches.

Track 6: Obesity, Metabolism, and Endocrine Regulation

This session examines the endocrine and metabolic mechanisms linking obesity with diabetes and hormonal disorders. It highlights appetite regulation, adipose tissue biology, and emerging weight-loss therapies. Discussions include medical and surgical interventions. The track supports holistic obesity management.

Track 7: Endocrine Disorders and Hormonal Imbalances

This track covers a wide spectrum of endocrine disorders affecting metabolic and systemic health. It focuses on diagnosis, treatment, and long-term management of hormonal imbalances. Emphasis is placed on clinical evaluation and endocrine testing. The session highlights multidisciplinary care approaches.

Track 8: Thyroid Disorders and Metabolic Impact

This session focuses on thyroid diseases and their effects on metabolism and cardiovascular health. It covers autoimmune thyroid conditions, nodules, and thyroid cancer. Emphasis is placed on early diagnosis and personalized treatment. The track highlights advances in thyroid care.

Track 9: Diabetes Complications and Comorbidity Management

This track addresses microvascular and macrovascular complications associated with diabetes. It focuses on early detection, prevention, and integrated management of comorbidities. Discussions emphasize multidisciplinary care and patient safety. The goal is to reduce disease-related morbidity.

Track 10: Cardiovascular and Renal Endocrinology

This session highlights the complex interaction between endocrine disorders, cardiovascular disease, and kidney health. It focuses on risk assessment, prevention, and therapeutic strategies. Emphasis is placed on cardiometabolic protection. The track supports integrated clinical care.

Track 11: Precision Medicine and Personalized Diabetes Care

This track focuses on individualized diabetes and endocrine care using genetic and molecular data. It explores biomarkers, predictive analytics, and tailored therapies. Emphasis is placed on improving treatment efficacy and safety. The session highlights the future of personalized healthcare.

Track 12: Digital Health, AI, and Diabetes Technologies

This session explores technological innovations transforming diabetes management and endocrine care. It includes digital platforms, AI-driven analytics, and remote monitoring tools. Emphasis is placed on improving access and patient engagement. The track highlights future-ready healthcare solutions.

Track 13: Nutrition, Lifestyle Medicine, and Behavioral Health

This track emphasizes lifestyle-based approaches to diabetes prevention and management. It focuses on nutrition therapy, physical activity, and behavioral interventions. Discussions highlight sustainable lifestyle changes. The session supports holistic patient care.

Track 14: Diabetes and Endocrine Disorders in Special Populations

This session addresses unique challenges in managing diabetes across different age groups and populations. It includes pediatric, gestational, and geriatric diabetes care. Emphasis is placed on individualized treatment strategies. The track highlights inclusive healthcare approaches.

Track 15: Public Health, Epidemiology, and Global Diabetes Burden

This track focuses on population-level trends, prevention strategies, and global health policies. It addresses health disparities and socioeconomic factors influencing diabetes prevalence. Emphasis is placed on sustainable healthcare solutions. The session supports global disease prevention.

Track 16: Endocrine Oncology and Metabolic Cancers

This session explores cancers of endocrine origin and their metabolic implications. It focuses on early diagnosis, targeted therapies, and multidisciplinary cancer care. Emphasis is placed on precision oncology. The track highlights advances in endocrine cancer management.

Track 17: Diabetes Education, Self-Management, and Patient Engagement

This track highlights the role of education and empowerment in chronic disease management. It focuses on self-care strategies, health literacy, and patient engagement models. Emphasis is placed on long-term adherence and outcomes. The session supports patient-centered care.

Track 18: Future Trends and Innovations in Diabetes and Endocrinology

This forward-looking session explores emerging therapies and future healthcare models. It highlights regenerative medicine, gene therapy, and novel diagnostics. Discussions focus on innovation and sustainability in healthcare. The track shapes the future of endocrine science.

MARKET ANALYSIS REPORT:

The global diabetes and endocrinology market is witnessing robust and sustained growth, driven by the rising prevalence of diabetes and metabolic disorders, aging populations, lifestyle changes, and rapid advancements in diagnostic and therapeutic technologies. Diabetes has become one of the most pressing global health challenges, with increasing incidence of both Type 1 and Type 2 diabetes, alongside a growing burden of endocrine disorders such as thyroid diseases, obesity-related hormonal imbalances, and metabolic syndromes. These trends are accelerating demand for specialized clinical care, advanced research, precision medicine, and interdisciplinary collaboration across endocrinology and metabolic healthcare.

In 2025, the global diabetes and endocrinology market is estimated to be valued at approximately USD 1.1 trillion and is projected to reach around USD 1.9 trillion by 2032, growing at a compound annual growth rate (CAGR) of about 6.2%. This growth is fueled by factors such as increasing diabetes prevalence, expansion of insulin and non-insulin therapies, rising adoption of continuous glucose monitoring and insulin pump technologies, and growing emphasis on early diagnosis and preventive care. According to global health estimates, over 530 million adults are currently living with diabetes, a figure expected to rise significantly by 2030, intensifying the need for specialized endocrinology services and evidence-based clinical solutions.

The market encompasses multiple segments, including diabetes therapeutics, endocrine diagnostics, digital health solutions, clinical services, education and training, and research and development. Among these, diabetes management technologies and precision endocrinology solutions are experiencing particularly strong growth. Geographically, North America and Europe lead the market due to advanced healthcare infrastructure, strong research ecosystems, and high adoption of innovative therapies. Meanwhile, Asia-Pacific, Latin America, and the Middle East, including Spain’s growing role as a European hub for medical research and international scientific events, are emerging as high-growth regions due to rising disease prevalence, healthcare investments, and expanding clinical research activities.

Within this evolving global landscape, international conferences in diabetes and endocrinology play a vital role. They serve as strategic platforms for disseminating cutting-edge research, fostering collaboration between clinicians, researchers, industry leaders, and policymakers, and addressing critical challenges such as disease prevention, healthcare access, and workforce training. Conferences also support knowledge translation from research to practice, promote innovation, and enable global dialogue on managing the growing diabetes and endocrine disease burden. Despite challenges such as healthcare disparities and rising treatment costs, opportunities abound through digital health expansion, preventive care strategies, and international research collaboration—positioning diabetes and endocrinology conferences as essential drivers of progress in global metabolic health.

Past Conference Report – 2023

The Diabetes and Endocrinology Conference 2023 was successfully held with strong international participation from endocrinologists, diabetologists, clinicians, researchers, academicians, and healthcare professionals. The scientific program focused on advancing diabetes research, endocrine disorders management, and evidence-based clinical practice. Key sessions addressed insulin therapies, metabolic health, thyroid disorders, and emerging research trends. The event provided a dynamic platform for scientific exchange, professional networking, and interdisciplinary collaboration, setting a solid foundation for future editions.

Past Conference Report – 2024

Building on its earlier success, the Diabetes and Endocrinology Conference 2024 expanded its global reach, welcoming participants from diverse clinical, academic, and industry backgrounds. The program highlighted innovations in diabetes technologies, precision endocrinology, digital health integration, and personalized treatment strategies. Engaging keynote lectures, panel discussions, and research presentations stimulated in-depth discussions on improving patient outcomes and advancing translational research. The conference reinforced its reputation as a leading international forum for diabetes and endocrine professionals.

Past Conference Report – 2025

The Diabetes and Endocrinology Conference 2025 marked a significant milestone by showcasing cutting-edge research, advanced clinical practices, and transformative healthcare solutions. With increased participation from global experts, early-career researchers, and industry leaders, the conference emphasized innovation, AI-enabled care, metabolic disease prevention, and evidence-driven clinical decision-making. Sessions addressed critical topics such as diabetes complications, endocrine oncology, digital therapeutics, and global health equity. The 2025 edition strengthened international collaborations and reaffirmed the conference’s commitment to shaping the future of diabetes and endocrinology research and care worldwide.

Abstracts enquiry

Registration enquiry

Contact Enquiry

Phone

WhatsApp

Useful Links

News

Newsletter

About

Diabetes and Endocrinology